Thomas Mcnaughton
First SEC filing: June 8, 2010 · Latest: June 8, 2010
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 1, 2013 | HBIO | J | 11,806 | · | · | 49,028 Direct | +31.72% | Acquired | (price as of 2026-10-02) |
| Nov. 1, 2013 | HBIO | J | 25,097 | · | · | 103,954 Direct | +31.83% | Acquired | (price as of 2026-10-02) |
| Nov. 1, 2013 | HBIO | J | 15,852 | · | · | 65,852 Direct | +31.70% | Acquired | (price as of 2026-10-02) |
| Nov. 1, 2013 | HBIO | J | 63,557 | · | · | 263,557 Direct | +31.78% | Acquired | (price as of 2026-10-02) |
| Nov. 1, 2013 | HBIO | J | 31,702 | · | · | 131,702 Direct | +31.70% | Acquired | (price as of 2026-10-02) |
| Nov. 1, 2013 | HBIO | J | 25,192 | · | · | 171,613 Direct | +17.21% | Acquired | (price as of 2026-10-02) |
| May 31, 2013 | HBIO | A | 37,222 | · | · | 37,222 Direct | · | Acquired | (price as of 2026-10-02) |
| May 31, 2013 | HBIO | A | 19,337 | · | · | 146,420 Direct | +15.22% | Acquired | (price as of 2026-10-02) |
| June 1, 2012 | HBIO | A | 79,037 | · | · | 79,037 Direct | · | Acquired | (price as of 2026-10-02) |
| June 1, 2012 | HBIO | A | 41,273 | · | · | 127,083 Direct | +48.10% | Acquired | (price as of 2026-10-02) |
| June 2, 2011 | HBIO | A | 50,000 | · | · | 50,000 Direct | · | Acquired | (price as of 2026-10-02) |
| June 2, 2011 | HBIO | A | 25,000 | · | · | 85,810 Direct | +41.11% | Acquired | (price as of 2026-10-02) |
| Jan. 25, 2011 | HBIO | F | 5,990 | $4.08 | $24,439 | 60,810 Direct | -8.97% | Disposed | -73.0% (price as of 2026-10-02) |
| June 4, 2010 | HBIO | A | 66,800 | · | · | 66,800 Direct | · | Acquired | (price as of 2026-10-02) |
| May 21, 2009 | HBIO | A | 200,000 | $3.18 | $636,000 | 200,000 Direct | · | Acquired | -65.4% (price as of 2026-10-02) |
| Nov. 14, 2008 | HBIO | A | 100,000 | $2.82 | $282,000 | 100,000 Direct | · | Acquired | -61.0% (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 1, 2013 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share | $3.64 | May 31, 2023 | 11,806 | Acquired |
| Nov. 1, 2013 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share | $2.56 | June 1, 2022 | 25,097 | Acquired |
| Nov. 1, 2013 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share | $4.04 | June 2, 2021 | 15,852 | Acquired |
| Nov. 1, 2013 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share | $2.28 | May 21, 2019 | 63,557 | Acquired |
| Nov. 1, 2013 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share | $2.02 | Nov. 14, 2018 | 31,702 | Acquired |
| May 31, 2013 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share | $5.08 | May 31, 2023 | 37,222 | Acquired |
| June 1, 2012 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share | $3.57 | June 1, 2022 | 79,037 | Acquired |
| June 2, 2011 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share | $5.64 | June 2, 2021 | 50,000 | Acquired |
| May 21, 2009 | HBIO | Stock Option (right to buy) | Common Stock, par value $0.01 per share | $3.18 | May 21, 2019 | 200,000 | Acquired |
| Nov. 14, 2008 | HBIO | Incentive Stock Option (right to buy) | Common Stock, par value $0.01 per share | $2.82 | Nov. 14, 2018 | 100,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2013 | $257,500 | · | · | $96,666 | · | · | $13,014 | $465,412 |
| 2012 | $309,000 | · | · | · | · | · | $12,500 | $613,001 |
| 2011 | $309,000 | · | · | · | · | · | $13,997 | $610,972 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.